At PMC, we believe that ethical integrity is the foundation of every successful clinical development program. In a landscape where regulatory frameworks, scientific innovation, and patient safety intersect, maintaining the highest ethical standards is not optional—it is essential.
A recent publication in Medicine, Science and the Law (SAGE Publishing) titled:
“Informed consent in clinical research: Medico-legal standards, ethical challenges and forensic implications in UK and EU frameworks”,
authored by a multidisciplinary team including PMC Experts, underscores the central role of informed consent in safeguarding participants, ensuring compliance, and protecting the integrity of clinical research. The article examines:
- Medico-legal standards across UK and EU regulatory frameworks.
- Ethical challenges arising in increasingly complex Clinical Trials.
- Forensic and liability considerations for Sponsors, Investigators and Research Institutions.
At PMC, this publication reflects our commitment to embedding Ethics at every stage of clinical development. Our team supports life sciences organisations in:
- Designing patient-centered, compliant clinical programs.
- Navigating regulatory complexity with confidence.
- Ensuring scientific rigour and legal robustness in all research activities.
We understand that in today’s world, ethical excellence and regulatory compliance are not just requirements—they are competitive advantages. PMC partners with clients to transform these principles into strategic value, helping them deliver innovative therapies safely, efficiently and responsibly.
PMC 